Smith & Nephew breaks into new woundcare segment with BlueSky buy
This article was originally published in Clinica
Executive Summary
UK medical device multinational Smith & Nephew is to boost its advanced wound care division with the acquisition of BlueSky Medical, a privately-held, US company operating in the $1.2bn negative pressure wound therapy (NPWT) market.
You may also be interested in...
Smith & Nephew Publishes Meta-Analysis Suggesting PICO's Wound Therapy Reduces Surgical Site Infections
Smith & Nephew's meta-analysis of 16 peer-reviewed publications shows prophylactic application of the company's PICO Negative Pressure Wound Therapy System reduces surgical site infections by 58% and wound rupturing along the surgical incision by 26%, while cutting the average hospital stay by a half day.
Market Intel: Intense Competition, Innovation Drive Healing Trends In Wound Care
The global advanced wound-care market is expected to reach $10.4bn by 2020, driven by massive competition, and forcing companies to innovate constantly to address the rising prevalence of chronic wound injuries, diabetic foot ulcers and burns. While regulatory and reimbursement challenges prevail, opportunities in this highly segmented market, in particular, in the advanced wound-dressings sector, are vast, with double-digit revenue growth potential.
ASA Finds 'Irresponsible' Weight Loss Ad Difficult To Stomach
Vision Healthcare’s Sensilab pulled Facebook advertisements for its weight loss supplements after UK regulator the Advertising Standards Authority launched an investigation into whether the marketing, which featured slim models, was "irresponsible."